𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zatebradine: Pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects

✍ Scribed by W. Roth; E. Bauer; G. Heinzel; P. J. G. Cornelissen; R. G. L. Van Tol; J. H. G. Jonkman; P. B. M. Zuiderwijk

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
727 KB
Volume
82
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of ketotiffn after oral
Pharmacokinetics of ketotiffn after oral administration to healthy male subjects
✍ Dr A. Grahnén; A. Lönnebo; O. Beck; S-Å Eckernäs; B. Dahlström; B. Lindström 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB 👁 2 views

## Abstract The pharmacokinetics of 2 mg ketotifen from four different oral dosage forms were examined in two randomized, balanced cross‐over studies. Forty healthy male subjects participated. Each of 20 subjects received two capsule formulations and each of the other 20 subjects received two syrup

Pharmacokinetics of L-FMAUS, a new antiv
Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability
✍ Hye J. Chung; Joo H. Lee; Sung J. Woo; Hee K. Park; Chang H. Koo; Myung G. Lee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Abstract The pharmacokinetics of L‐FMAUS after intravenous and oral administration (20, 50 and 100 mg/kg) to rats, gastrointestinal first‐pass effect of L‐FMAUS (50 mg/kg) in rats, __in vitro__ stability of L‐FMAUS, blood partition of L‐FMAUS between plasma and blood cells of rat blood, and prot

Dose-independent pharmacokinetics of a n
Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects
✍ Mi H. Lee; Soo K. Bae; Eun J. Kim; Yoon G. Kim; Sun-O. Kim; Dong H. Lee; Hong Li 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

The purpose of this study was to report dose-independent pharmacokinetics of KR-31543, a new neuroprotective agent for ischemia-reperfusion damage, after intravenous (iv) and oral (po) administration and first-pass effects after iv, intraportal, intragastric, and intraduodenal administration in rats